Literature DB >> 6093377

In vitro mutagenesis of a putative DNA binding domain of SV40 large-T.

D Kalderon, A E Smith.   

Abstract

A large number of deletion and point mutations were introduced into a small region of the SV40 large-T gene that was believed to encode part of a DNA-binding domain. The majority of mutant proteins constructed were unable to stimulate viral DNA replication, but all retained at least some transforming activity. Those replication-defective mutants with lesions affecting amino acid residues between 144 and 156 were postulated also to be defective in the autoregulation function of large-T to account for their ability to transform Rat-1 cells more avidly than wild-type. Two mutants (Glu 107----Lys and Ser 189----Asn) were isolated which exhibited severely reduced transforming activity but which supported normal rates of virus and viral DNA replication. Mutation of individual serine and threonine phosphorylation sites within the amino-terminal half of large-T had little effect on the protein's transforming activity. These and other mutations that affected amino acid residues either side of the region from 127 to 133, previously shown to be essential to the nuclear localisation of large-T [D. Kalderon, W. D. Richardson, A. F. Markham, and A. E. Smith (1984) Nature (London) 311, 33-38] did not discernibly impair nuclear accumulation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093377     DOI: 10.1016/0042-6822(84)90334-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  119 in total

1.  Regulation of endogenous E2F1 stability by the retinoblastoma family proteins.

Authors:  F Martelli; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Regions and activities of simian virus 40 T antigen that cooperate with an activated ras oncogene in transforming primary rat embryo fibroblasts.

Authors:  Tina M Beachy; Sara L Cole; Jane F Cavender; Mary J Tevethia
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation.

Authors:  H H Chao; A M Buchmann; J A DeCaprio
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

4.  Peptides containing cyclin/Cdk-nuclear localization signal motifs derived from viral initiator proteins bind to DNA when unphosphorylated.

Authors:  Ronald J Kim; Stephanie Moine; Danielle K Reese; Peter A Bullock
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1.

Authors:  Marina Cotsiki; Rowena L Lock; Yuan Cheng; Grace L Williams; Jean Zhao; David Perera; Raimundo Freire; Alan Entwistle; Erica A Golemis; Thomas M Roberts; Parmjit S Jat; Ole V Gjoerup
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

Review 6.  Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture.

Authors:  E Fanning
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

7.  The carboxy-terminal segment of the human cytomegalovirus DNA polymerase accessory subunit UL44 is crucial for viral replication.

Authors:  Laurie A Silva; Arianna Loregian; Gregory S Pari; Blair L Strang; Donald M Coen
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

8.  Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization.

Authors:  A Larose; N Dyson; M Sullivan; E Harlow; M Bastin
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

9.  The N-terminal side of the origin-binding domain of simian virus 40 large T antigen is involved in A/T untwisting.

Authors:  L Chen; W S Joo; P A Bullock; D T Simmons
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

10.  Large T-antigen mutants define multiple steps in the initiation of simian virus 40 DNA replication.

Authors:  I J Mohr; M P Fairman; B Stillman; Y Gluzman
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.